Novo Nordisk has signed a deal with AI-driven protein design company Gensaic to develop tissue-targeted therapies for ...
The artificial intelligence (AI) industry has been on a tear in the past two years, and judging by analyst estimates, it's ...
Class actions are gaining momentum in the food and beverage sector, according to Law.com Radar. The platform surfaced 24 ...
Novo Nordisk (NVO) is advancing 4% after the drug maker cut the price of its very popular weight-loss drug, Wegovy, by over ...
Anthropic AI reaches a total valuation of $61.5 billion after raising $3.5 billion during its late funding round.